Clinical Trials Browser

Phase 1/2 × Liver Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00293436 2012-09-17

Celecoxib and Erlotinib in Treating Patients With Liver Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms